Affective symptomatology in schizophrenia: a risk factor for tardive dyskinesia?

Author： Schulze T.G. Muller D.J. Krauss H. Marwinski K. Maroldt A.-O. Novo y Fernandez A. Fimmers R. Held T. Maier W. Nothen M.M. Rietschel M.

Publisher： Elsevier

ISSN： 0924-9338

Source： European Psychiatry, Vol.16, Iss.1, 2001-02, pp. : 71-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Focus on Lower Risk of Tardive Dyskinesia with Atypical Antipsychotics

By Nasrallah Henry

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 1, 2006-01 ,pp. : 57-62

Informa Healthcare

Access to resources Recommend Favorite

Rational Antipsychotic Choice: Weighing the Risk of Tardive Dyskinesia and Metabolic Syndrome

By Stoklosa Joseph Öngür Dost

Harvard Review of Psychiatry, Vol. 19, Iss. 5, 2011-09 ,pp. : 271-276

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Do Tardive Dyskinesia and l-Dopa Induced Dyskinesia Share Common Genetic Risk Factors? An Exploratory Study

By Greenbaum Lior Goldwurm Stefano Zozulinsky Polina Lifschytz Tzuri Cohen Oren Yahalom Gilad Cilia Roberto Tesei Silvana Asselta Rosanna Inzelberg Rivka Kohn Yoav Hassin-Baer Sharon Lerer Bernard

Journal of Molecular Neuroscience, Vol. 51, Iss. 2, 2013-10 ,pp. : 380-388

Humana Press, Inc

Access to resources Recommend Favorite

Tardive dyskinesia due to risperidone

By Sakkas P. Liappas J. Christodoulou G.

European Psychiatry, Vol. 13, Iss. 2, 1998-01 ,pp. : 107-108

Elsevier

Access to resources Recommend Favorite

Olanzapine and improvement of tardive dyskinesia

By Kucerova H.

European Psychiatry, Vol. 17, Iss. 7, 2002-11 ,pp. : 421-424

Elsevier

Access to resources Recommend Favorite